Can Exercise Ameliorate Immunosenescence and Thereby Reduce Relapse in Head and Neck Cancer Patients
1 other identifier
interventional
180
1 country
1
Brief Summary
Through the implementation of this three-year project, investigators expect to find a safe and effective exercise prescription for patients with oral cancer after surgery. The findings will encourage and promise and add further support to the concept that exercise prescription is worth implementation as part of care for the patients with head and neck cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2023
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 3, 2023
CompletedFirst Submitted
Initial submission to the registry
February 21, 2024
CompletedFirst Posted
Study publicly available on registry
February 28, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2027
ExpectedFebruary 28, 2025
February 1, 2025
2.5 years
February 21, 2024
February 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
% of participants with phenoage and age
To evaluate the phenoage acceleration by calculating differencehe of patients with phenoage and age.
1 month, after CCRT
% of participants with phenoage and age
To evaluate the phenoage acceleration by calculating differencehe of patients with phenoage and age.
6 month, after CCRT
Peak VO2 (ml/min/kg) of participants
To record the Peak VO2 (ml/min/kg) of participants and to evulate the effectiveness of exercise training
baseline
Peak VO2 (ml/min/kg) of participants
To record the Peak VO2 (ml/min/kg) of participants and to evulate the effectiveness of exercise training
1 month, after CCRT
Peak VO2 (ml/min/kg) of participants
To record the Peak VO2 (ml/min/kg) of participants and to evulate the effectiveness of exercise training
6 month, after CCRT
Questionnaire of European Organisation for Research and Treatment of Cancer Quality of Life Head and Neck Module (EORTC QLQ-HN43)
To assese the quality of life at the Head and Neck participants and evulate the effectiveness of exercise training.The minimum value is 43 and the maximum value is 172
baseline
Questionnaire of European Organisation for Research and Treatment of Cancer Quality of Life Head and Neck Module (EORTC QLQ-HN43)
To assese the quality of life at the Head and Neck participants and evulate the effectiveness of exercise training.The minimum value is 43 and the maximum value is 172
1 month, after CCRT
Questionnaire of European Organisation for Research and Treatment of Cancer Quality of Life Head and Neck Module (EORTC QLQ-HN43)
To assese the quality of life at the Head and Neck participants and evulate the effectiveness of exercise training.The minimum value is 43 and the maximum value is 172
6 month, after CCRT
Study Arms (2)
Head and Neck patient after CCRT treatment with HIIT training
EXPERIMENTALAfter CCRT treatment 4-5 week arrange HIIT training for patient. Two to three times a week ,total 24-36 times. keep follow the PFS and OS
Head and Neck patient after CCRT treatment
NO INTERVENTIONkeep follow the PFS and OS
Interventions
After CCRT treatment 4-5 week arrange HIIT excise for patient two to three times a week 24-36 times. And record of physical activities at home. According to the record set goal to acheive.
After CCRT treatment 4-5 week arrange HIIT excise for patient two to three times a week 24-36 times.
Eligibility Criteria
You may qualify if:
- Age ≥20
- Pathology:Squamous cell carcinoma
- Need CCRT treatment
- ECOG PS\<2
- Agree with blood drawing, excise training, questionnaire
You may not qualify if:
- ECOG PS≥2
- Unable to tolerate basic exercise, or CCRT treatment
- Mental illness or any medical illness or concurrent illness that may be aggravated by exercise training or unmanageable
- Any medical condition that unsuitable for exercise
- Disagree to trial procedures: exercise, blood draws, questionnaire
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
TuCheng Hospital
New Taipei City, 23652, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Chia-Hsun Hsieh
New Tipei City Tucheng Hospital
Central Study Contacts
Kuo
CONTACT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
February 21, 2024
First Posted
February 28, 2025
Study Start
May 3, 2023
Primary Completion
October 30, 2025
Study Completion (Estimated)
October 30, 2027
Last Updated
February 28, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share